Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377224644> ?p ?o ?g. }
- W4377224644 endingPage "309" @default.
- W4377224644 startingPage "299" @default.
- W4377224644 abstract "Treatment with chemoimmunotherapy (CIT) is considered an appropriate front-line treatment option for chronic lymphocytic leukemia (CLL). However, outcomes remain suboptimal. Bruton tyrosine kinase inhibitor (BTKi) combined with anti-CD20 antibody is an effective treatment for treatment-naïve, relapsed/refractory CLL patients. A systematic review and meta-analysis of randomized controlled trials was performed to compare the efficacy and safety of CIT versus BTKi + anti-CD20 antibody as front-line treatment for CLL patients. The endpoints of interest included progression-free survival (PFS), overall survival (OS), overall response rate (ORR), complete response (CR) rate, and safety. Four trials (including 1479 patients) were available as of December 2022 and fulfilled the eligibility criteria. BTKi + anti-CD20 antibody treatment significantly prolonged PFS [hazard ratio (HR), 0.25; 95% confidence interval (CI), 0.15-0.42] compared with CIT, while the combination therapy did not significantly improve OS compared with CIT (HR, 0.73; 95% CI, 0.50-1.06). We observed consistent benefits for PFS among patients with unfavorable features. Although pooled analysis indicated that the addition of BTKi to anti-CD20 antibody led to a higher ORR than CIT [risk ratio (RR), 1.16; 95% CI, 1.13-1.20], there was no difference in CR between the two arms (RR, 1.10; 95% CI, 0.27-4.55). The risk of grade ≥3 adverse effects (AE) was comparable between the two groups (RR, 1.04; 95% CI, 0.92-1.17). The BTKi + anti-CD20 antibody therapy has superior outcomes compared with CIT among patients with treatment-naïve CLL, without excess of toxicity. Future studies should compare next-generation targeted agent combinations versus CIT to determine the optimal management of CLL patients." @default.
- W4377224644 created "2023-05-23" @default.
- W4377224644 creator A5017393612 @default.
- W4377224644 creator A5026688698 @default.
- W4377224644 creator A5053832418 @default.
- W4377224644 creator A5067601374 @default.
- W4377224644 creator A5078067660 @default.
- W4377224644 date "2023-05-23" @default.
- W4377224644 modified "2023-10-17" @default.
- W4377224644 title "Efficacy and Safety of Bruton Tyrosine Kinase Inhibitor Plus Anti-CD20 Antibody Therapy Compared With Chemoimmunotherapy as Front-line Treatment for Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials" @default.
- W4377224644 cites W1712566393 @default.
- W4377224644 cites W2001850157 @default.
- W4377224644 cites W2066357502 @default.
- W4377224644 cites W2088095316 @default.
- W4377224644 cites W2095308469 @default.
- W4377224644 cites W2116835043 @default.
- W4377224644 cites W2120319857 @default.
- W4377224644 cites W2129358485 @default.
- W4377224644 cites W2135216058 @default.
- W4377224644 cites W2140606816 @default.
- W4377224644 cites W2142099365 @default.
- W4377224644 cites W2295348655 @default.
- W4377224644 cites W2337485820 @default.
- W4377224644 cites W2396328865 @default.
- W4377224644 cites W2519500141 @default.
- W4377224644 cites W2525969549 @default.
- W4377224644 cites W2705118184 @default.
- W4377224644 cites W2769052922 @default.
- W4377224644 cites W2787863642 @default.
- W4377224644 cites W2886452066 @default.
- W4377224644 cites W2902484351 @default.
- W4377224644 cites W2902706178 @default.
- W4377224644 cites W2915082572 @default.
- W4377224644 cites W2923453543 @default.
- W4377224644 cites W2948436219 @default.
- W4377224644 cites W2964876593 @default.
- W4377224644 cites W2973195462 @default.
- W4377224644 cites W2976280418 @default.
- W4377224644 cites W2980937306 @default.
- W4377224644 cites W2981487409 @default.
- W4377224644 cites W3016538158 @default.
- W4377224644 cites W3095071536 @default.
- W4377224644 cites W3118615836 @default.
- W4377224644 cites W3130132423 @default.
- W4377224644 cites W3185756680 @default.
- W4377224644 cites W3186824000 @default.
- W4377224644 cites W3212937433 @default.
- W4377224644 cites W4205825534 @default.
- W4377224644 cites W4205969691 @default.
- W4377224644 cites W4223904810 @default.
- W4377224644 cites W4284883545 @default.
- W4377224644 doi "https://doi.org/10.1097/cji.0000000000000471" @default.
- W4377224644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37216406" @default.
- W4377224644 hasPublicationYear "2023" @default.
- W4377224644 type Work @default.
- W4377224644 citedByCount "0" @default.
- W4377224644 crossrefType "journal-article" @default.
- W4377224644 hasAuthorship W4377224644A5017393612 @default.
- W4377224644 hasAuthorship W4377224644A5026688698 @default.
- W4377224644 hasAuthorship W4377224644A5053832418 @default.
- W4377224644 hasAuthorship W4377224644A5067601374 @default.
- W4377224644 hasAuthorship W4377224644A5078067660 @default.
- W4377224644 hasConcept C126322002 @default.
- W4377224644 hasConcept C141071460 @default.
- W4377224644 hasConcept C143998085 @default.
- W4377224644 hasConcept C168563851 @default.
- W4377224644 hasConcept C207103383 @default.
- W4377224644 hasConcept C2777938653 @default.
- W4377224644 hasConcept C2778461978 @default.
- W4377224644 hasConcept C2778714382 @default.
- W4377224644 hasConcept C2780790343 @default.
- W4377224644 hasConcept C2908647359 @default.
- W4377224644 hasConcept C44249647 @default.
- W4377224644 hasConcept C71924100 @default.
- W4377224644 hasConcept C90924648 @default.
- W4377224644 hasConcept C99454951 @default.
- W4377224644 hasConceptScore W4377224644C126322002 @default.
- W4377224644 hasConceptScore W4377224644C141071460 @default.
- W4377224644 hasConceptScore W4377224644C143998085 @default.
- W4377224644 hasConceptScore W4377224644C168563851 @default.
- W4377224644 hasConceptScore W4377224644C207103383 @default.
- W4377224644 hasConceptScore W4377224644C2777938653 @default.
- W4377224644 hasConceptScore W4377224644C2778461978 @default.
- W4377224644 hasConceptScore W4377224644C2778714382 @default.
- W4377224644 hasConceptScore W4377224644C2780790343 @default.
- W4377224644 hasConceptScore W4377224644C2908647359 @default.
- W4377224644 hasConceptScore W4377224644C44249647 @default.
- W4377224644 hasConceptScore W4377224644C71924100 @default.
- W4377224644 hasConceptScore W4377224644C90924648 @default.
- W4377224644 hasConceptScore W4377224644C99454951 @default.
- W4377224644 hasIssue "8" @default.
- W4377224644 hasLocation W43772246441 @default.
- W4377224644 hasLocation W43772246442 @default.
- W4377224644 hasOpenAccess W4377224644 @default.
- W4377224644 hasPrimaryLocation W43772246441 @default.
- W4377224644 hasRelatedWork W1823414859 @default.
- W4377224644 hasRelatedWork W1977027915 @default.
- W4377224644 hasRelatedWork W1996957538 @default.